Stablecoin Development Shares Surged 115% on Tuesday
The digital asset firm hit a 52-week high after aggressive moves to overhaul its share structure.
Updated on Sept. 29, 2026 in Corporate Finance
Live Poll
Do you trust sudden major price swings in small-cap stocks as a reliable investment opportunity?
Stablecoin Development Corporation stock rose 115.29% to $3.38 on Tuesday, driven by a trading volume of over 161 million shares. This rally follows the company's recent pivot to digital asset infrastructure and a series of corporate governance filings.
Why it matters
The company’s rapid valuation shift reflects heightened market interest in its treasury holdings of over 2.3 billion SKY tokens. Investors are reacting to a streamlined capital structure as the firm transitions away from its former identity as a pharmaceutical business.
Shares rose 115.29% on Tuesday, with trading volume reaching 161 million shares compared to a 100-day average of 1.62 million shares. The company currently holds 2,314,948,613 SKY tokens, representing 10% of the total supply.
The players
Stablecoin Development Corporation
A digital asset infrastructure company that formerly operated as NovaBay Pharmaceuticals.
David Garcia Rios
A member of the board of directors appointed to the firm on September 2.
The details
Stablecoin Development Corporation recently filed to withdraw legacy preferred stock designations to facilitate the creation of 5,000,000 new preferred shares for future flexibility. The firm also submitted an amended S-3 shelf registration statement on September 16, accounting for 212.9 million common shares. These regulatory shifts coincide with the company’s April 2026 pivot from its former role as NovaBay Pharmaceuticals to a digital asset infrastructure focus.
Timeline
The company transitioned to digital asset infrastructure in April 2026.
On September 2, 2026, the company withdrew old preferred stock classes and added a new board member.
By mid-September 2026, the firm’s treasury holdings reached approximately 2.31 billion SKY tokens.
An amended S-3 shelf registration was filed on September 16, 2026.
The stock price surged during the trading session on September 29, 2026.
Market Landscape
This volatility follows the company's April 2026 strategic pivot from its legacy pharmaceutical business model. The current trading behavior highlights an aggressive market repricing of firms shifting their underlying assets toward digital infrastructure.
Operators should monitor the company's use of the newly authorized 5,000,000 preferred shares as a signal for future capital raises or acquisitions. Consult with your financial advisor regarding how sudden stock volatility in micro-cap digital asset firms impacts broader sector exposure.
The takeaway
The company’s market performance highlights how quickly capital markets respond to structural pivots paired with digital asset treasury holdings. Operators should track the company's S-3 filings for indicators of how and when the firm intends to utilize its newly registered equity capacity.
Further reading
For broader trends in equity restructuring and market volatility, review our Corporate Finance section.
Source note: This article includes information reported by Benzinga.
Live Poll
Do you trust sudden major price swings in small-cap stocks as a reliable investment opportunity?
